Balsm Alofoq Medical Company

Balsm Alofoq Medical Company

TTADAWUL:9620
22.00
SAR
0.00
(0.00%)
60.00MMarket Cap

Total Valuation

SAR

As of June 30, 2026, Balsm Alofoq Medical Company carries a market capitalization of 60.00M, placing it among publicly traded companies globally. Its enterprise value stands at 50.08M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap60.00M
Enterprise Value50.08M

Share Statistics

As of June 30, 2026, Balsm Alofoq Medical Company has 2.50M shares outstanding.

Shares Outstanding2.50M

Valuation Ratios

These figures are as of June 30, 2026.

PB Ratio1.89
P/TBV Ratio1.89

Financial Position

As of June 30, 2026, Balsm Alofoq Medical Company maintains a current ratio of 7.67, meaning it holds 7.7x the short-term assets needed to cover near-term liabilities.

Current Ratio7.67
Quick Ratio4.66
Debt / Equity9.49

Stock Price Statistics

SAR

As of the close on November 17, 2026, Balsm Alofoq Medical Company's stock has declined approximately 17.29% over the past 52 weeks. The 50-day moving average sits at 22.86, while the 200-day moving average is 25.56.

52-Week Price Change-17.29%
50-Day Moving Average22.86
200-Day Moving Average25.56

Balance Sheet

SAR

As of June 30, 2026, Balsm Alofoq Medical Company holds 12.93M in cash and equivalents against 3.01M in total debt, resulting in a net debt position of -12.93M. Total book value stands at 31.70M, with working capital of 18.51M providing operational flexibility.

Cash & Cash Equivalents12.93M
Total Debt3.01M
Net Debt-12.93M
Equity (Book Value)31.70M
Book Value Per Share12.68
Working Capital18.51M

Stock Splits

Balsm Alofoq Medical Company's most recent stock split took place on December 22, 2025 with a 1:2 split ratio.

Last Split Date12/22/2025
Split Ratio1:2